샘플 요청 목록

 카트 문의
시장보고서
상품코드
1398752

세계의 원내감염 대책 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(-2031년) - 제품별, 최종사용자별, 지역별

Hospital Acquired Infection Control Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 201 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 원내감염 대책 시장 규모는 크게 성장하여 2024년 전체 매출이 68억 달러에 달하고 2031년 말에는 96억 달러에 달할 것으로 예상됩니다.

지난 10년간 첨단 의료기술의 도입으로 의료를 둘러싼 환경은 크게 변화했습니다. 감염성 질환과 만성질환이 급증하면서 소독 및 멸균 장비의 필요성이 그 어느 때보다 높아지고 있습니다.

의료 관련 감염에 대한 일반 대중의 인식이 높아지면서 감염 관리의 필요성이 높아지고 있습니다. 의료 시설의 감염 관리 시스템을 강화하기 위한 정부 프로그램은 시장 확대에 매우 중요한 역할을 하고 있습니다. 감염 및 전염병의 발병률 증가는 감염 관리 기술에 대한 수요를 촉진하고 있습니다. 팬데믹으로 인해 의료 현장에서 감염 관리의 중요성이 부각되면서 관련 장비에 대한 수요 증가로 이어지고 있습니다.

본 보고서는 세계의 원내감염 대책 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등을 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나와 러시아의 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 세계의 원내감염 대책 시장 전망, 2018-2031년

  • 세계의 원내감염 대책 시장 전망, 제품별, 금액(10억 달러), 수량(100만 개), 2018-2031년
  • 세계의 원내감염 대책 시장 전망, 최종사용자별, 금액(10억 달러), 수량(100만 개), 2018-2031년
  • 세계의 원내감염 대책 시장 전망, 지역별, 금액(10억 달러), 수량(100만 개), 2018-2031년

제4장 북미의 원내감염 대책 시장 전망, 2018-2031년

제5장 유럽의 원내감염 대책 시장 전망, 2018-2031년

제6장 아시아태평양의 원내감염 대책 시장 전망, 2018-2031년

제7장 라틴아메리카의 원내감염 대책 시장 전망, 2018-2031년

제8장 중동 및 아프리카의 원내감염 대책 시장 전망, 2018-2031년

제9장 경쟁 상황

  • 제품과 최종사용자 히트맵
  • 제조업체와 최종사용자 히트맵
  • 기업의 시장 점유율 분석, 2023년
  • 경쟁 대시보드
  • 기업 개요
    • Olympus Corporation
    • Medivators Inc.(Cantel Medical Corp.)
    • Getinge Group
    • STERIS Plc.
    • Belimed AG(Metall Zug)
    • Steelco S.P.A.
    • Pfizer Inc.,
    • F. Hoffmann-La Roche Ltd,
    • Merck & Co.,
    • Advanced Sterilization Products Services Inc.
    • Abbott Laboratories
    • Bayer AG
    • The 3M Company
    • Cepheid Inc.
    • UVision360 Inc.

제10장 부록

ksm 24.01.03

The Hospital Acquired Infection Control Market is poised for substantial growth, with worldwide revenue reaching US$ 6.8 Billion in 2024 and anticipated to propel the market to US$ 9.6 Billion by the end of 2031, according to the latest report by Fairfield Market Research.

Changing Healthcare Infrastructure and the Demand for Infection Control

Over the past decade, the healthcare landscape has undergone significant transformations, marked by the adoption of advanced medical technologies. As the prevalence of infectious and chronic diseases has surged, the need for disinfection and sterilization equipment has never been more critical.

Driving Factors for Hospital Acquired Infection Control Market Expansion

Several factors are contributing to the growing demand for hospital-acquired infection control technology:

  • Rising Public Awareness: Increasing awareness about healthcare-associated infections among the public is driving the need for infection control measures.
  • Government Initiatives: Government programs aimed at strengthening infection control systems in medical facilities are playing a pivotal role in market expansion.
  • Prevalence of Infectious Diseases: The rising incidence of infectious and communicable diseases is fueling the demand for infection control technology.
  • Impact of COVID-19: The pandemic underscored the importance of infection control in healthcare settings, leading to increased demand for related equipment.

Manufacturers Expanding Their Markets

Manufacturers in the hospital acquired infection control market are expanding their reach through various strategies:

  • Increased awareness about personal hygiene is driving the demand for sterilized medical equipment, especially as the number of surgical procedures rises.
  • The demand for nosocomial infection control equipment is growing as people recognize the benefits of sterilization.
  • Minimally invasive procedures and the rise of outpatient services are contributing to market growth.
  • Increasing government initiatives and growing public awareness are expanding the number of outpatients, further driving market progress.

Challenges in Market Progress

While the hospital acquired infection control market holds immense potential, challenges exist:

  • The complexity of infection control methods and the need for advanced technologies can be obstacles.
  • Reprocessing technology for medical devices poses challenges in ensuring their safety for reuse, affecting market expansion to some extent.

Booming Market in the United States

The United States presents a highly lucrative market for hospital-acquired infection control equipment due to its advanced healthcare system, high healthcare costs, and widespread public awareness of infection control issues. It is expected to generate a significant share of the region's revenue.

Emerging Market in China

China is emerging as a prominent market for hospital-acquired infection control, driven by increasing public awareness of hospital-acquired infections, government support programs, and a rising number of such infections. China is expected to dominate in terms of revenue share.

Focus on India

India, as the second-most populous country in the world, offers substantial potential for hospital-acquired infection control equipment suppliers. As hygiene awareness and attention to healthcare intensify, India is likely to experience significant growth in demand for disinfection equipment. The nation's healthcare infrastructure is expected to advance rapidly over the next decade, presenting opportunities for local market players.

Competitive Landscape

The healthcare-associated infections segment has gained significant attention, prompting key industry players to invest in research and development and launch new products. Some key companies profiled in the hospital acquired infection control market include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc.

Market Segmentation

By Product :

  • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Disinfection Equipment
  • Disinfector
    • Washer Disinfector
    • Flusher Disinfector
  • Endoscopic Reprocessor Systems
    • Single Basin Endoscopic Reprocessor Systems
    • Dual Basin Endoscopic Reprocessor Systems
  • Disinfectants

By End User :

  • Hospitals
  • Ambulatory Surgical Centres
  • Medical Institutions
  • Diagnostic Laboratories
  • Clinics

By Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hospital Acquired Infection Control Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 3.1. Global Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Heat Sterilization Equipment
        • 3.1.1.1.1. Moist Heat Sterilization Equipment
        • 3.1.1.1.2. Dry Heat Sterilization Equipment
      • 3.1.1.2. Low-Temperature Sterilization Equipment
      • 3.1.1.3. Radiation Sterilization Equipment
      • 3.1.1.4. Disinfection Equipment
        • 3.1.1.4.1. Disinfector
          • 3.1.1.4.1.1. Disinfector
            • 3.1.1.4.1.1.1. Washer Disinfector
            • 3.1.1.4.1.1.2. Flusher Disinfector
        • 3.1.1.4.2. Flusher Disinfector
      • 3.1.1.5. Endoscopic Reprocessor Systems
        • 3.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 3.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 3.1.1.6. Disinfectants
  • 3.2. Global Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ambulatory Surgical Centres
      • 3.2.1.3. Medical Institutions
      • 3.2.1.4. Diagnostic Laboratories
      • 3.2.1.5. Clinics
  • 3.3. Global Hospital Acquired Infection Control Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 4.1. North America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Heat Sterilization Equipment
        • 4.1.1.1.1. Moist Heat Sterilization Equipment
        • 4.1.1.1.2. Dry Heat Sterilization Equipment
      • 4.1.1.2. Low-Temperature Sterilization Equipment
      • 4.1.1.3. Radiation Sterilization Equipment
      • 4.1.1.4. Disinfection Equipment
        • 4.1.1.4.1. Disinfector
          • 4.1.1.4.1.1. Disinfector
            • 4.1.1.4.1.1.1. Washer Disinfector
            • 4.1.1.4.1.1.2. Flusher Disinfector
        • 4.1.1.4.2. Flusher Disinfector
      • 4.1.1.5. Endoscopic Reprocessor Systems
        • 4.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 4.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 4.1.1.6. Disinfectants
  • 4.2. North America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Ambulatory Surgical Centres
      • 4.2.1.3. Medical Institutions
      • 4.2.1.4. Diagnostic Laboratories
      • 4.2.1.5. Clinics
  • 4.3. North America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.2. U.S. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.3. Canada Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.4. Canada Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 5.1. Europe Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Heat Sterilization Equipment
        • 5.1.1.1.1. Moist Heat Sterilization Equipment
        • 5.1.1.1.2. Dry Heat Sterilization Equipment
      • 5.1.1.2. Low-Temperature Sterilization Equipment
      • 5.1.1.3. Radiation Sterilization Equipment
      • 5.1.1.4. Disinfection Equipment
        • 5.1.1.4.1. Disinfector
          • 5.1.1.4.1.1. Disinfector
            • 5.1.1.4.1.1.1. Washer Disinfector
            • 5.1.1.4.1.1.2. Flusher Disinfector
        • 5.1.1.4.2. Flusher Disinfector
      • 5.1.1.5. Endoscopic Reprocessor Systems
        • 5.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 5.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 5.1.1.6. Disinfectants
  • 5.2. Europe Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Ambulatory Surgical Centres
      • 5.2.1.3. Medical Institutions
      • 5.2.1.4. Diagnostic Laboratories
      • 5.2.1.5. Clinics
  • 5.3. Europe Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.2. Germany Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.3. U.K. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.4. U.K. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.5. France Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.6. France Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.7. Italy Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.8. Italy Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.9. Turkey Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.10. Turkey Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.11. Russia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.12. Russia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.13. Rest of Europe Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.14. Rest of Europe Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Heat Sterilization Equipment
        • 6.1.1.1.1. Moist Heat Sterilization Equipment
        • 6.1.1.1.2. Dry Heat Sterilization Equipment
      • 6.1.1.2. Low-Temperature Sterilization Equipment
      • 6.1.1.3. Radiation Sterilization Equipment
      • 6.1.1.4. Disinfection Equipment
        • 6.1.1.4.1. Disinfector
          • 6.1.1.4.1.1. Disinfector
            • 6.1.1.4.1.1.1. Washer Disinfector
            • 6.1.1.4.1.1.2. Flusher Disinfector
        • 6.1.1.4.2. Flusher Disinfector
      • 6.1.1.5. Endoscopic Reprocessor Systems
        • 6.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 6.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 6.1.1.6. Disinfectants
  • 6.2. Asia Pacific Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Ambulatory Surgical Centres
      • 6.2.1.3. Medical Institutions
      • 6.2.1.4. Diagnostic Laboratories
      • 6.2.1.5. Clinics
  • 6.3. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.2. China Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.3. Japan Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.4. Japan Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.5. South Korea Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.6. South Korea Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.7. India Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.8. India Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.9. Southeast Asia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.10. Southeast Asia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 7.1. Latin America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Heat Sterilization Equipment
        • 7.1.1.1.1. Moist Heat Sterilization Equipment
        • 7.1.1.1.2. Dry Heat Sterilization Equipment
      • 7.1.1.2. Low-Temperature Sterilization Equipment
      • 7.1.1.3. Radiation Sterilization Equipment
      • 7.1.1.4. Disinfection Equipment
        • 7.1.1.4.1. Disinfector
          • 7.1.1.4.1.1. Disinfector
            • 7.1.1.4.1.1.1. Washer Disinfector
            • 7.1.1.4.1.1.2. Flusher Disinfector
        • 7.1.1.4.2. Flusher Disinfector
      • 7.1.1.5. Endoscopic Reprocessor Systems
        • 7.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 7.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 7.1.1.6. Disinfectants
  • 7.2. Latin America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Ambulatory Surgical Centres
      • 7.2.1.3. Medical Institutions
      • 7.2.1.4. Diagnostic Laboratories
      • 7.2.1.5. Clinics
  • 7.3. Latin America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.2. Brazil Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.3. Mexico Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.4. Mexico Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.5. Argentina Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.6. Argentina Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Heat Sterilization Equipment
        • 8.1.1.1.1. Moist Heat Sterilization Equipment
        • 8.1.1.1.2. Dry Heat Sterilization Equipment
      • 8.1.1.2. Low-Temperature Sterilization Equipment
      • 8.1.1.3. Radiation Sterilization Equipment
      • 8.1.1.4. Disinfection Equipment
        • 8.1.1.4.1. Disinfector
          • 8.1.1.4.1.1. Disinfector
            • 8.1.1.4.1.1.1. Washer Disinfector
            • 8.1.1.4.1.1.2. Flusher Disinfector
        • 8.1.1.4.2. Flusher Disinfector
      • 8.1.1.5. Endoscopic Reprocessor Systems
        • 8.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 8.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 8.1.1.6. Disinfectants
  • 8.2. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Ambulatory Surgical Centres
      • 8.2.1.3. Medical Institutions
      • 8.2.1.4. Diagnostic Laboratories
      • 8.2.1.5. Clinics
  • 8.3. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.2. GCC Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.3. South Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.4. South Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.5. Egypt Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.6. Egypt Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.7. Nigeria Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.8. Nigeria Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs End User Heatmap
  • 9.2. Manufacturer vs End User Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Olympus Corporation
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Medivators Inc. (Cantel Medical Corp.)
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Getinge Group
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. STERIS Plc.
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Belimed AG (Metall Zug)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Steelco S.P.A.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Pfizer Inc.,
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. F. Hoffmann-La Roche Ltd,
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Merck & Co.,
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Abbott Laboratories
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Bayer AG
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. The 3M Company
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Cepheid Inc.
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. UVision360 Inc.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제